Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed Jul 22, 2019 · 10-Q · 22 days after period end · 0001091818-19-000192
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Revenue | $5.96K | $5.06K |
| Net Income | -$7.18K | -$28.53K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Jul 22, 2019 · 22 d after period end